United States · 
What does FCA Venture Partners invest in?
FCA Venture Partners invests most often at Series A and Venture (61% of the rounds on record), in sectors such as Connected Health, Well-being and Healthcare.
FCA Venture Partners highlights
- 01
3 cheques in the last 12 months
- 02
Mostly Series A and Venture: 61% of its rounds
- 03
Sole investor in 14 rounds, median $4.3M
- 04
3 exits from the portfolio
What they do
FCA Venture Partners invests in companies poised to transform healthcare.From their own website
- Type
- VC firm (from a list, unverified)
- Cheque size
- Not stated
- Stages
- SeedSeries ASeries BGrowth
- Sectors
- Connected HealthWell-beingHealthcare
- Based in
- Nashville, United States
- Cold pitches
- Not accepted
The record
Every round we can evidence, newest first65 appearances
- 2026
3 rounds
- Jul
- May
- Feb
- 2025
11 rounds
- Oct
- Aug
- Aug
- Jul
- Jun
- Apr
- Feb
- Jan
- Jan
- Jan
- Jan
- 2024
6 rounds
- Nov
- Sept
- Jul
- May
- Jan
- Jan
- 2023
6 rounds
- Nov
- Sept
- Jun
- May
- May
- Jan
- 2022
2 rounds
- Apr
- Feb
- 2021
3 rounds
- Jul
- Feb
- Feb
- 2020
1 round
- Mar
- 2019
2 rounds
- Apr
- Apr
- 2017
1 round
- May
- 2015
1 round
- Mar
- 2014
10 rounds
- Nov
- Aug
- Jul
- Jul
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The team
Named by the firm itself, on a filing, its Form ADV or its company registration11 named
AJAndrew J. BouldinExecutive OfficeriFiling they signed
C(Charles (Todd) W. JohnsonManaging PartneriForm ADV
JAJames A. PattonExecutive OfficeriFiling they signed
JRJohn R. Burch, Jr.Mr. Burch is the Vice President and a director of the issuer's general partner, Clayton Ventures V, LLC.iFiling they signed
JRJohn R BurchVice PresidentiForm ADV
MAMatthew A. KingMr. King is the President and a director of the issuer's general partner, Clayton Ventures V, LLC.iFiling they signed
NRNancy R. AllenMs. Allen is the Secretary of the issuer's general partner, Clayton Ventures V, LLC.iFiling they signed
SRStuart R. McWhorterMr. McWhorter is a director of the issuer's general partner, Clayton Ventures V, LLC.iFiling they signed
TKThomas K HearnManaging PartneriForm ADV
TKThomas K. Hearn IIIDirectoriFiling they signed
WLWhitney L. KalbPartner/General CounseliForm ADV
We also hold 23 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
What the register says
From the firm's own filings with the SEC, which it must file accurately by law
$380Mgross assets of its funds, 5 advisers combinedOct 2026
Exemptreporting adviserventure or small private funds
- Legal name
- FCA Venture Partners VII Management LLC
- SEC number
- CRD 319570
What they claim to have backed
From their own portfolio page (on their website)
32 of 46 we have independently watched raise
Azra AI's softwareBranchLab’s AI platformCaregiving solution thatCasechek's platform automatesClinical Ink enhancesEblusolutionsEnable Dental bringsEvolvedmdFlexible, real-time patientGoCheck's vision screeningIgniteData automates theImpiricus enables pharmaIntegrated research organizationKerafastMobile IV access,Nvolve's software platformPatient communication platformPatient engagement softwarePatient payment systemPlatform expanding accessProvidertrustReal-time patient intelligenceRemedly provides multi-specialtyRubiconMD enables primaryShiftWizardTech enabled NEMTTechnology driven platformTechnology driven therapyTechnology-enabled services platformValue-based provider deliveringWatershed Health worksWellth rewards membersAI powered clinicalAPI infrastructure andChartWiseClinical trial paymentsCloud video captureComprehensive behavioral healthDigital platform offeringDigital readmission andDrughunterIdentalsoftLumereMedical Reimbursements ofModern payment platformTechnology enabled care
Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.
Exits from the portfolio
Companies it backed that were later bought or listed3 in all
ONFocus HealthcareBought by MedeAnalyticsUndisclosedNov 2014
ProxsysBought by Athenahealth$28MJul 2011
An exit counts when it came after the firm's first round in the company. From historical deal records.